The weight-loss drugs being tested in 2025: will they beat Ozempic?
In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial of its experimental drug CagriSema — a combination of semaglutide and a medicine called cagrilintide. People on CagriSema lost about 23% of their body weight in a 68-week study, outperforming both drugs when taken alone.
Explainer: How do weight-loss drugs work?
We talk Ozempic, Wegovy and Mounjaro. A number of studies have shown the amazing weight loss potential of a new group of drugs, known to many by their brand names as Ozempic (which is for diabetes), Wegovy and Mounjaro. But how do these new drugs work? How were they discovered and who can use them?
Here are the health pros and cons of GLP-1RA weight loss drugs
New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers continue to analyze their health
The dark side of weight loss drugs no one warns about
New research uncovers hidden risks and surprising benefits of weight loss drugs like Ozempic, reshaping how we see these popular medications.
Prescriptions for weight loss drugs are skyrocketing, especially among young women. Experts think they know why.
The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating."
How Weight-Loss Drugs Can Upend a Marriage
When Jeanne began to seriously consider taking Zepbound, one of the new-generation weight-loss drugs, she had the briefest of conversations with her husband, Javier. They were in
Super Bowl ad accused of misleading consumers about weight loss drugs
Two senators and an industry group are calling for an FDA review of a Super Bowl ad by the telehealth platform Hims and Hers.
A Super Bowl ad about weight loss drugs takes on America's 'broken' health care system. Health experts and 2 senators aren't happy about it.
Hims & Hers Health is set to have a commercial air during Super Bowl LIX. It’s already courting controversy, with calls to bar the game’s host, Fox, from broadcasting it. Why? Experts, advocates and politicians are saying that the 60-second spot — which deems obesity “America’s deadliest epidemic,
Cosmetic surgeons try to correct 'Ozempic face' for weight-loss drug users
Add surgical tweaks to fix so-called "Ozempic face" to the list of top trending cosmetic procedures, as tallied by the ...
Weight Loss Drug Super Bowl Ad Raises Questions About Compounded Vs. Branded Meds
An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use ...
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Eli Lilly expects to provide results from a study in people with obesity and osteoarthritis of the knee in 2025.
Lilly reassures investors that weight-loss drug demand is strong, shares rise
Eli Lilly on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing ...
Hims & Hers responds to controversy over Super Bowl weight loss drug commercial: 'We're calling for change'
Hims & Hers believes that is where the controversy lies. “We called on the industry and said that they need to change — and ...
Half of Americans Support Weight-Loss Drugs Like Ozempic for Obesity, Poll
Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...
Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short
Eli Lilly reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and ...
Whoopi Goldberg warns against 'phony' weight loss ad using AI version of her likeness
Whoopi Goldberg warned the public to not believe a "phony" weight loss ad made with artificial intelligence using her ...